bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Update

bioMérieux S.A. (OTCMKTS:BMXMF) was the target of a large decline in short interest in August. As of August 31st, there was short interest totalling 225,800 shares, a decline of 15.5% from the August 15th total of 267,100 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 2,258.0 days.

bioMérieux Stock Performance

Shares of BMXMF stock remained flat at $122.50 during trading hours on Tuesday. bioMérieux has a 1-year low of $90.23 and a 1-year high of $122.52. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.19 and a current ratio of 2.03. The business has a 50-day simple moving average of $108.90 and a 200 day simple moving average of $105.86.

Analyst Upgrades and Downgrades

Separately, UBS Group raised bioMérieux to a “strong-buy” rating in a report on Thursday, August 22nd.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.